Introduction: Patients with congenital hypothyroidism (CH) may transiently show a certain degree of pituitary resistance to levothyroxine (LT4) which, however, normalizes subsequently. However, in some individuals TSH fails to normalize despite adequate LT4 treatment.
Methods: Nine patients with CH followed in three Academic Centre who developed over time a resistance to thyroid hormones underwent extensive biochemical and genetic analyses. These latter were performed by Sanger sequence or targeted Next Generation Sequencing technique including a panel of candidate genes involved in thyroid hormone actions and CH: THRA, THRB, DIO1, DIO2, SLC16A2, SECISBP2, DUOX2, DUOXA2, FOXE1, GLIS3, IYD, JAG1, NKX2-1, NKX2.5, PAX8, SLC26A4, SLC5A5, TG, TPO, TSHR.
Results: All patients displayed a normal sensitivity to TH in the first years of life, but developed variable degrees of resistance to LT4 treatment at later stages. In all cases TSH normalized only in the presence of high FT4 levels. T3 suppression test followed by TRH stimulation was performed in two cases and was compatible with central resistance to thyroid hormones. This biochemical feature was present independently on the cause of CH, being observed either in patients with an ectopic (N=2) or an eutopic gland (N=3) or in case of agenesis (N=1). None of the patients had genetic variants in genes involved in the regulation of thyroid hormone actions, while in two cases we found two double heterozygous missense variants in TSHR and GLIS3 or in DUOX2 and SLC26A4 genes, respectively.
Conclusions: We report CH patients who showed an acquired and unexplainable pituitary refractoriness to thyroid hormone action.